Atrial Fibrillation Surgery Market Size & Share, Growth Analysis 2035

Global Atrial Fibrillation Surgery Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Atrial Fibrillation Surgery Market size is estimated to reach ~USD 23 Billion by the end of 2035 by growing at a CAGR of ~17.50% over the forecast period, i.e., 2023 – 2035. In addition to this, in the year 2022, the market size of atrial fibrillation surgery was ~USD 3 Billion. The growth of the market can be attributed to the increasing number of people suffering from atrial fibrillation. According to reports, in the USA, 2.3 million people suffer from atrial fibrillation and this rate is projected to reach 5.6 million by the year 2050, with more than 50% of these individuals over the age of 80. Further, the advancements in technology in the field of atrial fibrillation surgery are expected to contribute to the growth of the market.

In addition to these, factors that are believed to fuel the market growth of atrial fibrillation surgery include the increased preference to use catheter ablation procedures and products to treat cardiac arrhythmias. Catheter ablation is used especially in conditions where medicines and drugs are not working. For instance, in August 2020, Abbott Laboratories, a manufacturer of healthcare products and medical devices introduced the TactiFlex PAF IDE ablation catheter, which is used to treat a patient suffering from irregular heartbeat, and paroxysmal atrial fibrillation. It has sensors enabled for patients with atrial fibrillation (AFib) symptoms that cannot be treated with medicine. Further, the reduced mortality rate and positive outcomes of atrial fibrillation surgery are predicted to boost market growth in the forecast period.

Global Atrial Fibrillation Surgery Market: Growth Drivers and Challenges

Growth Drivers

Increasing Technological Advancements in the Field of Atrial Fibrillation Surgery – On account of the increasing technological advances in the field, the market is expected to expand more in the upcoming years. For instance, in 2022, a single lead ECG was developed to use machine learning to help detect patients with atrial fibrillation-induced heart failure.
Increasing Number of Digital Catheterization Labs in Hospitals – Advances in catheterization technology such as robot-assisted catheterization for cardiac catheterization have advanced the digital imaging system. This system allows physicians to perform coronary procedures in digital cath labs more effectively, allowing them to detect and treat cardiac disorders. These laboratories provide diagnostic services at hospitals, ambulatory surgical centers, and physician's offices for outpatient procedures. More than 1 million cardiac catheterization procedures are performed every year in the United States, primarily to diagnose and treat patients with suspected coronary heart disease.
Rise in People Suffering from Atrial Fibrillation Conditions – according to the data published on July 2022, by the Center for Disease Control and Prevention (CDC), stated that more than 454,000 hospitalizations happen, with atrial fibrillation as the primary diagnosis each year in the United States. The condition contributes to about 158,000 deaths each year in the U.S.
Rise in the Use of Catheter Ablation for Cardiac Arrhythmia Treatment – advanced technology is able to now generate very detailed images of heart tissue. This means that surgeons are able to precisely locate arrhythmia, which improves the operation's effectiveness. Surgeons can also use cryoablation, laser, and cryo energy-based ablation instead of RF-based ablation to treat individuals with arrhythmias. In 2020, the CASTLE trial results predicted a reduction of 38% in AF in patients who implanted the device in form of CRTD.

Challenges

High cost of ablation catheters- The demand for advanced devices to enhance the safety and efficiency of associated procedures has arisen as a result of the use of catheter ablation in treating atrial fibrillation. However, it is costly to install most of the devices that are enabled with technology such as 3D mapping and remote catheter navigation. This leads to a reduction in the number of individuals who are able to have catheter ablation surgery, especially in emerging countries. This is one of the major factors predicted to slow down the market growth.
Lack of skilled professionals
Increased preference for pharmaceutical medicines over atrial fibrillation treatment devices

Global Atrial Fibrillation Surgery Market Segmentation

The global atrial fibrillation surgery market is segmented and analyzed for demand and supply by procedure into catheter ablation, surgical ablation, and AV node ablation. Out of the three types of atrial fibrillation surgery, the catheter ablation segment is estimated to gain the largest market share of about ~38% in the year 2035. The growth of the segment can be attributed to the increasing effectiveness of catheter ablation procedures. This procedure is used to treat irregular heart rhythms especially when medicines and drugs seem to have no effect. This is considered a low-risk, minimally invasive, and highly precise treatment pathway. Catheter ablation has a 95% of success rate in the treatment of cardiac arrhythmias. Further, the new product launches by key players in the industry are also estimated to boost market growth. For instance, the TactiFlex PAF IDE ablation catheter was launched by Abbott Laboratories and is used to treat an irregular heartbeat. These factors are estimated to contribute to the growth of the segment in the forecast period.

The global atrial fibrillation surgery market is also segmented and analyzed for demand and supply by end-user into hospitals, ambulatory surgical centers, and others. Among these three segments, the ambulatory surgical centers segment is expected to garner a significant share of around ~40% in 2035. As a consequence of enhanced health infrastructure, availability of skilled labor, and affordability, the ambulatory surgical center segment is expected to see good growth. The rising patient pool and growing geriatric population suffering from lifestyle diseases, such as atherosclerosis and heart failure, are expected to propel the market. However, the advantages of minimally invasive surgeries ultimately lead to a growth in segments as opposed to conventional surgery. On January 2021, the Pathways organization has introduced a top membership program for ASCs, HST One. With the option of adding additional services as required, this membership program allows its end users to select from a selection of bundled popular products in which they themselves take part. The introduction of such differentiated services to ambulatory surgery centers increases the number of patients, which contributes to market growth. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global atrial fibrillation surgery market includes the following segments:

By Procedure	Catheter Ablation Surgical Ablation AV Node Ablation
By End User	Hospitals Ambulatory Surgical Centers Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Global Atrial Fibrillation Surgery Market Regional Synopsis

The market share of atrial fibrillation surgery in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~32% by the end of 2035. The market's growth can be attributed majorly to the increasing technological advancements in the region's atrial fibrillation surgery field. Further, the growing prevalence of cardiac conditions in the aging population is another factor that is anticipated to boost market growth. For instance, out of 18.2 million adults, 6.7 % of the adult population is affected by coronary heart disease. It is also estimated that 51% of heart procedures are performed on adults who are 65 and above years of age. The availability of more favorable insurance coverage is also estimated to contribute to the growth of the market in the United States, given its presence of key players. The US Food and Drug Administration granted Boston Scientific Corporation approval of the WATCHMAN FLXLARGE Left Atrial Appendage Closure LAAC device, in July 2020, indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF).

The Asia Pacific atrial fibrillation surgery market is estimated to be the second largest, registering a significant share by the end of 2035. The growth of the market can be attributed majorly to the increasing popularity of the use of minimum-invasive procedures in the region. Moreover, demand for the market is increasing due to rising healthcare costs. Furthermore, the technical advances in atrial fibrillation surgery have been considerable and this has raised the cure rate of patients. Growing obesity and heart disease rates across the region are also driving the atrial fibrillation industry. Additionally, heart disease is one of the leading causes of death worldwide. The number of people suffering from it is increasing exponentially due to a change in lifestyle. For these reasons, it is expected that the market for minimally invasive procedures increases as a result of advantages including reduced patient discomfort, injury, hospital stays, and faster recovery.

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the increasing prevalence of atrial fibrillation conditions and a rise in general awareness of the same. Moreover, the increased healthcare expenditure and growing disposable income are estimated to contribute to the growth of the market in the forecast period.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the atrial fibrillation surgery market?

Ans: Increasing technological advancements, new product launches, rise in people with atrial fibrillation conditions are the major factors driving the market growth.

2) What would be the CAGR of atrial fibrillation surgery market over the forecast period?

Ans: The market size of atrial fibrillation surgery is anticipated to attain a CAGR of ~17.50% over the forecast period, i.e., 2023 â€“ 2035.

3) What are the challenges affecting the atrial fibrillation surgery market growth?

Ans: High cost of ablation catheters, and lack of skilled professionals are estimated to be the growth hindering factors for the market expansion.

4) Which region will provide more business opportunities for growth of atrial fibrillation surgery market in future?

Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

5) Who are the major players dominating the atrial fibrillation surgery market?

Ans: The major players in the market are AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd., Abbott Laboratories.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the atrial fibrillation surgery market?

Ans: The market is segmented by procedure, end user, and region.

8) Which segment captures the largest market size in the procedure segment in the atrial fibrillation surgery market?

Ans: The catheter ablation segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Base Year	2022
Forecast Year	2023-2035
CAGR	~17.50%
Base Year Market Size (2022)	~ USD 3 Billion
Forecast Year Market Size (2035)	~ USD 23 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Atrial Fibrillation Surgery Market Size & Share, by Procedure (Catheter Ablation, Surgical Ablation, AV Node Ablation); End-user (Hospitals, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035